Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Pieri

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Blood|July 5, 2011
Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosisPaola Guglielmelli, Giovanni Barosi, Alessandro Rambaldi, et al.
Cancer Research|September 26, 2015
Osteogenic Potential of Mesenchymal Stromal Cells Contributes to Primary MyelofibrosisChristophe Martinaud, Christophe Desterke, Johanna Konopacki, et al.
American Journal of Hematology|April 5, 2012
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPNElisabetta Antonioli, Paola Guglielmelli, Lisa Pieri, et al.
American Journal of Hematology|July 22, 2014
Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms. An European Leukemia Net studyIda Martinelli, Valerio De Stefano, Alessandra Carobbio, et al.
The Journal of Allergy and Clinical Immunology|October 29, 2022
Disease correlates and clinical relevance of hereditary α-tryptasemia in patients with systemic mastocytosisBenedetta Sordi, Fiorenza Vanderwert, Francesca Crupi, et al.
Plos One|October 23, 2013
Complex patterns of chromosome 11 aberrations in myeloid malignancies target CBL, MLL, DDB1 and LMO2Thorsten Klampfl, Jelena D Milosevic, Ana Puda, et al.
American Journal of Hematology|November 24, 2016
Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasmsLisa Pieri, Chiara Paoli, Umberto Arena, et al.
Future Oncology (London, England)|September 13, 2018
The Italian Mastocytosis Registry: 6-year experience from a hospital-based registrySerena Merante, Virginia V Ferretti, Chiara Elena, et al.
American Journal of Hematology|April 11, 2016
Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patientsLisa Pieri, Patrizia Bonadonna, Chiara Elena, et al.
American Journal of Hematology|November 14, 2019
Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 casesEmanuela Sant'Antonio, Paola Guglielmelli, Lisa Pieri, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Blood|July 5, 2011
Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosisPaola Guglielmelli, Giovanni Barosi, Alessandro Rambaldi, et al.
Cancer Research|September 26, 2015
Osteogenic Potential of Mesenchymal Stromal Cells Contributes to Primary MyelofibrosisChristophe Martinaud, Christophe Desterke, Johanna Konopacki, et al.
American Journal of Hematology|April 5, 2012
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPNElisabetta Antonioli, Paola Guglielmelli, Lisa Pieri, et al.
American Journal of Hematology|July 22, 2014
Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms. An European Leukemia Net studyIda Martinelli, Valerio De Stefano, Alessandra Carobbio, et al.
The Journal of Allergy and Clinical Immunology|October 29, 2022
Disease correlates and clinical relevance of hereditary α-tryptasemia in patients with systemic mastocytosisBenedetta Sordi, Fiorenza Vanderwert, Francesca Crupi, et al.
Plos One|October 23, 2013
Complex patterns of chromosome 11 aberrations in myeloid malignancies target CBL, MLL, DDB1 and LMO2Thorsten Klampfl, Jelena D Milosevic, Ana Puda, et al.
American Journal of Hematology|November 24, 2016
Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasmsLisa Pieri, Chiara Paoli, Umberto Arena, et al.
Future Oncology (London, England)|September 13, 2018
The Italian Mastocytosis Registry: 6-year experience from a hospital-based registrySerena Merante, Virginia V Ferretti, Chiara Elena, et al.
American Journal of Hematology|April 11, 2016
Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patientsLisa Pieri, Patrizia Bonadonna, Chiara Elena, et al.
American Journal of Hematology|November 14, 2019
Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 casesEmanuela Sant'Antonio, Paola Guglielmelli, Lisa Pieri, et al.
Pageof 6